par dose (1 ml):
C. perfringens type A (α) anatoxine: ≥ 0,5 UI
C. perfringens type B & C (β) anatoxine: ≥ 20,5 UI
C. perfringens type D (ε) anatoxine: ≥ 5,9 UI
C. chauvoei anaculture: ≥ 90% de protection
C. novyi anatoxine: ≥ 3,8 UI
C. septicum anatoxine: ≥ 3,3 UI
C. tetani anatoxine: ≥ 4,5 UI
C. sordellii anatoxine: ≥ 4,4 U
C. haemolyticum anatoxine: ≥ 25,0 U
Adjuv: alun
vaccin injectable
sc
Dose: Bo: 2 ml, Ov: 1 ml
Vac de base:
-Bo (âge > 2 sem), Ov (âge > 2 sem): 2 doses à 4-6 sem d'intervalle
Rappel: Bo, Ov: 1 dose 6-12 m après vac de base
pendant gestation: 1 dose de rappel 8-2 sem avant mise-bas
OOI: 2 sem après vac de base
DOI active:
Bo: 12 m (C. tetani, C. perfringens type D), < 12 m (C. perfringens type A, B, C), < 6 m (C. novyi type B, C. septicum, C. sordellii, C. haemolyticum, C. chauvoei)
Ov: 12 m (C. perfringens type A, B, C, D, C. novyi type B, C. sordellii, C. tetani), < 6 m (C. septicum, C. haemolyticum, C. chauvoei)
DOI passive:
Bo: min 2 sem (C. sordellii, C. haemolyticum), min 8 sem (C. septicum, C. chauvoei), min 12 sem (C. perfringens type A, B, C, D, C. novyi type B, C. tetani)
Ov: min 2 sem (C. septicum, C. chauvoei), min 8 sem (C. perfringens type B, C), min 12 sem (C. perfringens type A, D, C. novyi type B, C. tetani, C. sordellii). Aucune immunité passive n’a été observée pour C. haemolyticum.
Temps d'attente: 0 j
flacon 50 ml
R/